Johnson and Johnson today
Johnson and Johnson
- 52 weeks
- 140.68 dollars
▼
169.99 dollars
- Profit
- 3.16 %
- P/E ratio.
- 18.33
- The target price
- $ 171.00
After years of normalization post -19 and its effect on Kenvue Spinoff, Johnson & Johnson’s New York: JNJ The stock price has returned in the assembly mode. It is still early in the game, but the results of the second quarter confirm that growth has returned, and the acceleration occurs and is expected to continue in the back half of the year.
The acceleration may be stronger than expected due to the expected approvals and the pipelines are offered to maintain the growth of this company in the long run. Fast food is that this Return of King’s capital Safe as it was always and will continue to grow in the foreseeable future.
The elements that are in line with the expectations for the collection of stock prices include price in 2025, random and MACD indicators, and the motion average group, which shows strong support in mid -July.
Pricing work is essential for the gathering thesis. He showed strong support at the level of $ 145 in 2023, 2024, and again in 2025, followed by a higher level at $ 150 later in the year. The transition to the highest support level indicates the progress of the upward morale, which was confirmed by increasing the price after the release.
The market has risen over the mobile intermediate range, which represents widespread support in the market, and the effects of purchasing signals in the indicators.
The Stochastic and Macd swared the ups of the ups and the weekly and daily plans, creating a strong purchase signal with a convergence of rapprochement. This indicates that a high percentage of market participants is behind this step.
The mobile, visible average averages group, a 30 -day moving average for traders and speculators, as well as EMAS for 150 days and 150 weeks for purchasing and purchasing investors. This collection is a long -term Launchpad platform in the long and sustainable results.
Johnson & Johnson has produced value -building results in Q2 2025
Johnson and Johnson expectations today
$ 171.00
3.77 % upModerate purchase
Based on 20 analyst classification
| The current price | 164.78 dollars |
|---|---|
| High expectations | 215.00 dollars |
| Average expectations | $ 171.00 |
| Low expectations | $ 150.00 |
Details of Johnson Johnson and Johnson expectations
Johnson & Johnson Q2 S2 had strength in both operating sectors, revealing the strength in the pharmaceutical industries and the wider. The company produced $ 23.7 billion of profit profits, an increase of 5.8 % compared to last year and 370 basis points better than expected.
The late winds FX affected the upper and lower part, but they are not the only reasons for strength. Operating performance and new products and demand for 7.8 % increased in American business and growth abroad.
In the sectoral way, medtech was stronger, with an increase of 7.3 % and 6.1 % modification growth, while innovative medicine grew by 4.9 % the amount of it and 3.8 % modification.
Margin news is also favorable to the gathering. Company Improving its total margin and operation Because of the quality and one Tailwinds FX, leaving the network at 5.54 billion dollars or an increase of 18 % compared to last year. The minimum of $ 2.77 in modified profits is better than the amount of MARKETIAT, which exceeds 330 basis points, and the margin is expected to remain strong at the end of the year.
JNJ instructions are an incentive for high stock prices
Johnson and Johnson guidelines are A higher incentive Stock prices. It includes increasing expectations for revenues and profits that exceeded consensus estimates in the middle of a point, and may be cautious. Decisive fast food is that expectations are in line with expectations to increase the capital return, which is strong. JNJ’s increasing re -equipment provides a modest lever for investors, as it reaps annual return by 3.35 %.
Analysts trends are in line with the emerging stock market in JNJ. It includes increasing the number of current reports, who are under the age of 12 months, a Moderate company buy classificationAnd target prices range around the level of $ 70.
The level of $ 70 is in line with the JNJ trading top for two years, which is the decisive resistance of this market and the trigger point.
Before you think about Johnson & Johnson, you will want to hear it.
Marketbeat follows the best research analyst at Wall Street, the best performance in Wall Street and the stocks they recommend to their customers on a daily basis. Marketbeat has identified the five shares whom the top analysts quietly whispered to their customers to buy now before hunting the broader market … Johnson & Johnson was on the list.
While Johnson & Johnson currently has a moderate purchase classification among analysts, higher -rated analysts believe that these five stocks buy better.
Show the five stocks here
Are you looking for the following FAANG stock before everyone hears it? Enter your email address to find out any stock of analysts who believe that the next Trillion Dollaar Tech Companyy.
